Jacobs Levy Equity Management’s AnaptysBio ANAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.59M Sell
28,625
-26,463
-48% -$1.42M 0.01% 626
2025
Q4
$2.67M Sell
55,088
-323,364
-85% -$12.6M 0.01% 536
2025
Q3
$11.6M Buy
378,452
+10,005
+3% +$230K 0.05% 269
2025
Q2
$8.18M Buy
368,447
+351,960
+2,135% +$7.37M 0.03% 339
2025
Q1
$306K Sell
16,487
-68,894
-81% -$1.15M ﹤0.01% 977
2024
Q4
$1.13M Buy
85,381
+39,307
+85% +$952K ﹤0.01% 695
2024
Q3
$1.54M Sell
46,074
-1,129
-2% -$38.6K 0.01% 651
2024
Q2
$1.18M Sell
47,203
-2,186
-4% -$50.9K ﹤0.01% 694
2024
Q1
$1.11M Buy
49,389
+13,764
+39% +$326K 0.01% 698
2023
Q4
$763K Sell
35,625
-171,160
-83% -$2.95M ﹤0.01% 769
2023
Q3
$3.71M Buy
206,785
+8,064
+4% +$154K 0.02% 434
2023
Q2
$4.04M Buy
198,721
+39,214
+25% +$795K 0.02% 442
2023
Q1
$3.47M Buy
+159,507
New +$3.88M 0.02% 471
2022
Q3
Sell
-15,196
Closed -$308K 990
2022
Q2
$308K Sell
15,196
-96,211
-86% -$2.13M ﹤0.01% 921
2022
Q1
$2.76M Buy
111,407
+22,090
+25% +$669K 0.02% 556
2021
Q4
$3.1M Buy
89,317
+889
+1% +$28.2K 0.02% 523
2021
Q3
$2.4M Sell
88,428
-738
-0.8% -$18.7K 0.02% 576
2021
Q2
$2.31M Sell
89,166
-5,039
-5% -$121K 0.02% 567
2021
Q1
$2.03M Buy
94,205
+22,827
+32% +$576K 0.02% 595
2020
Q4
$1.53M Buy
71,378
+527
+0.7% +$12.8K 0.01% 628
2020
Q3
$1.04M Buy
70,851
+7,260
+11% +$131K 0.01% 655
2020
Q2
$1.42M Buy
63,591
+29,006
+84% +$530K 0.02% 596
2020
Q1
$489K Buy
+34,585
New +$525K 0.01% 757

Other funds holding ANAB